Selbyville, Delaware, May 20, 2021 (GLOBE NEWSWIRE) -- According to estimates by seasoned analysts, global antibiotics market size was valued at USD 40.85 billion in 2020, and is anticipated to register 4.6% CAGR over 2021-2027, subsequently accruing USD 55.96 billion by the forecast period end.
Moreover, a clear depiction of the industry segmentation, on the basis of action mechanism and drug class, is provided in the study. In addition, the research piece factors in a complete examination of qualitative and quantitative factors pertaining to the geographical scope of the industry. Furthermore, it outlines the competitive hierarchy of leading companies while evaluating business strategies such as new product launches, mergers & acquisitions, and partnerships.
Rising investments and government support for research and development of antibiotic drugs, and high prevalence of infectious and chronic diseases are stimulating global antibiotics market growth.
Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3793335/
The continued efforts of pharmaceutical companies for development of new, superior quality antibiotic drugs is also propelling the industry remuneration. Moreover, the Proceedings of the National Academy of Science (PNAS) reported that the consumption rate of antibiotics rose by 39% during 2000-2015, which is further expected to increase by over 200% by the end of 2030.
For the unversed, antibiotics are defined as anti-microbial medicines that destroy or slow down the growth of bacteria and fight infections. Antibiotics are available in several different forms like capsules, pills, syrups and injections.
In spite of the positive outlook of global antibiotics industry, factors such as strict government regulations for medicine approval, and certain side effects caused by the use of antibacterial drugs are likely to slow down the business growth in the ensuing years.
Market segmentation overview:
Based on application scope, global antibiotics market is arrayed into DNA synthesis inhibitors, protein synthesis inhibitors, cell wall synthesis inhibitors, mycolic acid inhibitors, RNA synthesis inhibitors and others.
Moving on to drug class, the industry vertical is split into cephalosporin, carbapenem, penicillin, sulfonamide, fluoroquinolone, aminoglycoside, macrolide, 7-ACA and others.
To access a sample copy or view this report in detail along with the table of contents, please click the link below:
https://www.marketstudyreport.com/reports/global-antibiotics-market-size-research
Summary of regional outlook:
Expert analysts claim that Asia-Pacific accounted for the largest market share in the recent past and will likely witness strong gains over the forecast duration. This growth can be attributed to surging population and increasing number of prescriptions for antibiotic medicines in the region.
Meanwhile, the North America market is expected to garner a remarkable compound annual growth in the upcoming years. Availability of a substantial number of pharmaceutical manufacturers, as well as the rapid advancements in healthcare infrastructure are favoring the regional market expansion.
Global Antibiotics Market, by Action Mechanism (Revenue, USD billion, 2018-2027)
- DNA Synthesis Inhibitors
- Protein Synthesis Inhibitors
- Cell Wall Synthesis Inhibitors
- Mycolic Acid Inhibitors
- RNA Synthesis Inhibitors
- Others
Global Antibiotics Market, by Drug Class (Revenue, USD billion, 2018-2027)
- Cephalosporin
- Carbapenem
- Penicillin
- Sulfonamide
- Fluoroquinolone
- Aminoglycoside
- Macrolide
- 7-ACA
- Others
Global Antibiotics Market, by Regional Landscape (Revenue, USD billion, 2018-2027)
North America
- U.S.
- Canada
Europe
- UK
- France
- Italy
- Germany
- Spain
- ROE
Asia Pacific
- China
- South Korea
- Japan
- India
- Australia
- RoAPAC
Latin America
- Mexico
- Brazil
Rest of the World
Global Antibiotics Market Competitive Dashboard (Revenue, USD billion, 2018-2027)
- Melinta Therapeutics
- AbbVie Inc.
- Abbott Laboratories
- Merck & Co., Inc.
- Mylan N.V.
- Cumberland Pharmaceuticals, Inc.
- Nabriva Therapeutics plc
- GlaxoSmithKline plc
- Teva Pharmaceutical Industries Ltd.
- Novartis International A.G
Table of Content:
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Antibiotics Market, by Region, 2019-2027 (USD Billion)
1.2.2. Antibiotics Market, by Action Mechanism, 2019-2027 (USD Billion)
1.2.3. Antibiotics Market, by Drug Class, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Antibiotics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Antibiotics Market Dynamics
3.1. Antibiotics Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Investments in research and development of new antibiotic drugs
3.1.1.2. Increasing growth in the incidences of infection and chronic diseases
3.1.1.3. Constant support from the governments
3.1.2. Market Challenges
3.1.2.1. Strict government regulations for the approval of new medicines
3.1.2.2. Certain side effects of antibiotics
3.1.3. Market Opportunities
3.1.3.1. Prolonged increase in the demand of antibiotics
Chapter 4. Global Antibiotics Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2027)
4.2. PEST Analysis
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Antibiotics Market, by Action Mechanism
5.1. Market Snapshot
5.2. Global Antibiotics Market by Action Mechanism , Performance - Potential Analysis
5.3. Global Antibiotics Market Estimates & Forecasts by Action Mechanism 2018-2027 (USD Billion)
5.4. Antibiotics Market, Sub Segment Analysis
5.4.1. Cell Wall Synthesis Inhibitors
5.4.2. Protein Synthesis Inhibitors
5.4.3. DNA Synthesis Inhibitors
5.4.4. RNA Synthesis Inhibitors
5.4.5. Mycolic Acid Inhibitors
5.4.6. Others
Chapter 6. Global Antibiotics Market, by Drug Class
6.1. Market Snapshot
6.2. Global Antibiotics Market by Drug Class, Performance - Potential Analysis
6.3. Global Antibiotics Market Estimates & Forecasts by Drug Class 2018-2027 (USD Billion)
6.4. Antibiotics Market, Sub Segment Analysis
6.4.1. Cephalosporin
6.4.2. Penicillin
6.4.3. Fluoroquinolone
6.4.4. Macrolide
6.4.5. Carbapenem
6.4.6. Aminoglycoside
6.4.7. Sulfonamide
6.4.8. 7-ACA
6.4.9. Others
Chapter 7. Global Antibiotics Market, Regional Analysis
Related Report:
Global Covid-19 Vaccine Market - Analysis By Product Type, Patient Type, End User, By Region, By Country (2021 Edition): Market Insights, Competition and Forecast (2020-2030)
Global Covid-19 vaccine Market will be valued at approximately USD 25 billion in the year 2024. The growing government support for vaccine development and the increasing involvement of global organizations in the development of adequate vaccination facilities in endemic regions is anticipated to positively influence the sales of Coronavirus vaccine in the upcoming years. Moreover, the strong demand for coronavirus vaccine, the ongoing initiative initiatives by governments to procure the vaccine and the waves of infection is likely to drive the market growth during the forecast period.
Under the Patient Type segment, Covid-19 market for senior citizens is anticipated to witness the largest market share owing to the focus of the governments to vaccinate the vulnerable population, manufacturing of vaccines being outsourced and also manufacturers collaborating with hospitals and doctors to better understand their demand and meet their requirements will be pushing growth in the market for Covid-19 vaccine during the coming years.
Hospitals, followed by Clinics, Vaccination centers and Academic and research Institute will attain substantial market share as healthcare authorities and governments are trying their best to vaccinate the population to further avoid spread of coronavirus disease.
About US:
Market Study Report, LLC. is a hub for market intelligence products and services.
We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.
Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.
If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.